Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03207854 · ClinicalTrials.gov registry record
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
A clinical trial of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Neoplasm, sponsored by University of Southern California.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03207854 is a study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Neoplasm that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 500 participants, below the 948-participant average among 104 other Hematopoietic and Lymphoid Cell Neoplasm trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03207854, a study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Neoplasm, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This research trial collects and stores blood, tissue, and bone marrow specimens from patients with cancer or blood disorders, and healthy volunteers to study the immune system in a variety of different types of experiments, as well as associated clinical data as appropriate, focused on understanding mechanisms of immunotherapy.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Biomarker Analysis
- OTHER Questionnaire Administration
Study Locations (1)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-04-12 |
| Est. Completion | 2027-04-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03207854
The ClinicalTrials.gov registry entry for NCT03207854 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 948-participant average among 104 other Hematopoietic and Lymphoid Cell Neoplasm trials with a reported enrollment target (47% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Hematopoietic and Lymphoid Cell Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT03207854 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03207854 about?
NCT03207854 is a clinical study titled "Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers". This research trial collects and stores blood, tissue, and bone marrow specimens from patients with cancer or blood disorders, and healthy volunteers to study the immune system in a variety of different types of experiments, as well as associated clinical data as appropriate, focused on understandin...
What is the current status of trial NCT03207854?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-04-12. Estimated completion is 2027-04-12.
What conditions does trial NCT03207854 study?
This clinical trial studies the following conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Neoplasm, Healthy Subject, Hematologic and Lymphocytic Disorder, Immune System Disorder.
What interventions are being tested in trial NCT03207854?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER), Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT03207854?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03207854 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic and Lymphoid Cell Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
RECRUITING · NA
-
The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
RECRUITING
-
Role of Gut Microbiome in Cancer Therapy
RECRUITING
-
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
RECRUITING · Phase 2
-
Increasing Knowledge and Interest in Cancer Clinical Trials
RECRUITING · NA
Explore more on PlainTrial
Hematopoietic and Lymphoid Cell Neoplasm
All registered trials for this condition
Malignant Neoplasm
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.